theory clinical_31_7
imports Main

begin

typedecl entity
typedecl event

consts
  BetaCatenin :: "entity ⇒ bool"
  Gene :: "entity ⇒ bool"
  CyclinD1 :: "entity ⇒ bool"
  Expression :: "event ⇒ bool"
  Activate :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  NecessaryFor :: "event ⇒ entity ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Mutation :: "entity ⇒ bool"
  CTNNB1 :: "entity ⇒ bool"
  Activity :: "event ⇒ bool"
  Enhance :: "event ⇒ bool"
  LeadTo :: "event ⇒ event ⇒ bool"
  Promote :: "event ⇒ bool"
  Directly :: "event ⇒ bool"
  Cell :: "entity ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  DueTo :: "event ⇒ entity ⇒ bool"
  ResultIn :: "event ⇒ event ⇒ bool"

(* Explanation 1: β-catenin activates the expression of many genes, including cyclin D1, which is necessary for cell proliferation. *)
axiomatization where
  explanation_1: "∃x y z e1 e2. BetaCatenin x ∧ Gene y ∧ CyclinD1 z ∧ Expression e1 ∧ Activate e2 ∧ Agent e2 x ∧ Patient e2 y ∧ NecessaryFor e1 z ∧ Proliferation z"

(* Explanation 2: Activating mutations of CTNNB1 enhance the activity of β-catenin, leading to increased expression of genes like cyclin D1, which directly promotes cell proliferation. *)
axiomatization where
  explanation_2: "∃x y z w e1 e2 e3. Mutation x ∧ CTNNB1 y ∧ BetaCatenin z ∧ Gene w ∧ CyclinD1 w ∧ Activity e1 ∧ Enhance e2 ∧ Agent e2 x ∧ Patient e2 z ∧ LeadTo e2 e3 ∧ Expression e3 ∧ Promote e3 ∧ Agent e3 w ∧ Patient e3 z ∧ Directly e3"

(* Explanation 3: Enhanced activity of β-catenin, due to activating mutations of CTNNB1, directly promotes cell proliferation via β-catenin. *)
axiomatization where
  explanation_3: "∃x y z e1 e2. Activity e1 ∧ BetaCatenin x ∧ Mutation y ∧ CTNNB1 y ∧ Cell z ∧ Proliferation z ∧ Promote e2 ∧ Agent e2 x ∧ Patient e2 z ∧ Directly e2 ∧ Via e2 x ∧ DueTo e1 y"

(* Explanation 4: Activating mutations of CTNNB1 result in enhanced activity of β-catenin, which directly promotes the proliferation of cells via β-catenin. *)
axiomatization where
  explanation_4: "∃x y z e1 e2. Mutation x ∧ CTNNB1 x ∧ Activity e1 ∧ BetaCatenin y ∧ Cell z ∧ Proliferation z ∧ ResultIn e1 e2 ∧ Promote e2 ∧ Agent e2 x ∧ Patient e2 z ∧ Directly e2 ∧ Via e2 y"

theorem hypothesis:
  assumes asm: "Mutation x ∧ CTNNB1 y ∧ Cell z"
  (* Hypothesis: Activating mutations of CTNNB1 promote proliferation of cells via β-catenin. *)
  shows "∃x y z e. Mutation x ∧ CTNNB1 y ∧ Cell z ∧ Proliferation z ∧ BetaCatenin y ∧ Promote e ∧ Agent e x ∧ Patient e z ∧ Via e y"
proof -
  (* From the premise, we have known information about Mutation x, CTNNB1 y, and Cell z. *)
  from asm have "Mutation x ∧ CTNNB1 y ∧ Cell z" by blast
  (* Explanation 4 states that activating mutations of CTNNB1 result in enhanced activity of β-catenin, which directly promotes the proliferation of cells via β-catenin. *)
  (* This explanation directly relates to the hypothesis we are trying to prove. *)
  (* We can use the logical relation Implies(D, C) to infer that cell proliferation occurs. *)
  from explanation_4 have "∃e. Proliferation z ∧ BetaCatenin y ∧ Promote e ∧ Agent e x ∧ Patient e z ∧ Via e y" sledgehammer
  then show ?thesis <ATP>
qed

end
